STOCK TITAN

Ginkgo Bioworks Announces Participation in Cowen's 43rd Annual Health Care Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Ginkgo Bioworks (NYSE: DNA) is scheduled to participate in Cowen's 43rd Annual Health Care Conference on March 6, 2023. CEO Jason Kelly will take part in a fireside chat at 9:10 a.m. ET and a SynBio & AI Driven Drug Discovery panel at 4:40 p.m. ET. This involvement highlights the company's strategy to showcase its leadership in the cell programming and biosecurity sectors. Investors can find more details, including webcast links and replays, on the company's investor relations website.

Positive
  • Participation in a high-profile healthcare conference, enhancing visibility.
  • Opportunity for CEO to present Ginkgo's advancements in cell programming and biosecurity.
Negative
  • None.

BOSTON, March 2, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced today that Co-Founder and CEO Jason Kelly is scheduled to participate in Cowen's 43rd Annual Health Care Conference, including:

  • Fireside chat on Monday, March 6, 2023, at 9:10 a.m. ET
  • SynBio & AI Driven Drug Discovery panel on Monday, March 6, 2023, at 4:40 p.m. ET

Further details, webcast links, and a replay of the fireside chat and panel, if available, will be posted on the company's investor relations website at https://investors.ginkgobioworks.com/events/.

About Ginkgo Bioworks

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo's biosecurity and public health unit, Concentric by Ginkgo, is building global infrastructure for biosecurity to empower governments, communities, and public health leaders to prevent, detect and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and concentricbyginkgo.com, read our blog, or follow us on social media channels such as Twitter (@Ginkgo and @ConcentricByGBW), Instagram (@GinkgoBioworks and @ConcentricByGinkgo), or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com

MEDIA CONTACT:

press@ginkgobioworks.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-cowens-43rd-annual-health-care-conference-301759866.html

SOURCE Ginkgo Bioworks

FAQ

What is the date of Ginkgo Bioworks' participation in the Cowen Health Care Conference?

Ginkgo Bioworks will participate on March 6, 2023.

What time is Ginkgo's fireside chat at the Cowen Conference?

The fireside chat is scheduled for 9:10 a.m. ET.

Who is representing Ginkgo Bioworks at the Cowen Conference?

CEO Jason Kelly is representing Ginkgo Bioworks.

Where can I find more information about Ginkgo Bioworks' conference participation?

More information can be found on Ginkgo's investor relations website.

What panel is Jason Kelly participating in during the Cowen Conference?

Jason Kelly is participating in the SynBio & AI Driven Drug Discovery panel at 4:40 p.m. ET.

Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

DNA Rankings

DNA Latest News

DNA Stock Data

409.25M
42.27M
6.15%
68.55%
13.18%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
BOSTON